Insider · CIK 0001572448
Cheryl Pegus
Files at BSX (BOSTON SCIENTIFIC CORP), CON (Concentra Group Holdings Parent, Inc.). First filing May 21, 2026, latest May 21, 2026.
Cheryl Pegus files SEC Form 4 as director at BSX (BOSTON SCIENTIFIC CORP), and also at CON (Concentra Group Holdings Parent, Inc.). Since May 21, 2026, Cheryl Pegus has reported 1 open-market buy worth $100k and 0 open-market sells worth $0, the latest filed on May 21, 2026.
A track record needs three past buys with six months of prices behind them; Cheryl Pegus has 0, so none is measured yet.
The newest scored trade: bought $100k of BSX on May 20, 2026, filed May 21, 2026, scored 66 (notable). In the last 12 months: 1 buy worth $100k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BSX: BOSTON SCIENTIFIC CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 66Notable | BOSTON SCIENTIFIC CORP | $100k 1,770 shares | - | +8% from low-48% from high |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | BSX BOSTON SCIENTIFIC CORP | POpen-market purchase Common Stock | +1,770 | $56.49 | $100k | 1,770 | May 21, 2026 |
| May 7, 2026 | BSX BOSTON SCIENTIFIC CORP | AGrant or award Deferred Stock Unitsderivative | +3,800 | $0.00 | $0 | 9,717 | May 11, 2026 |
| May 7, 2026 | BSX BOSTON SCIENTIFIC CORP | AGrant or award Deferred Stock Unitsderivative | +1,281 | $0.00 | $0 | 10,998 | May 11, 2026 |
| Mar 2, 2026 | BSX BOSTON SCIENTIFIC CORP | AGrant or award Deferred Stock Unitsderivative | +24 | $0.00 | $0 | 5,917 | Mar 4, 2026 |
| Nov 4, 2025 | CON Concentra Group Holdings Parent, Inc. | AGrant or award Common Stock | +7,748 | $0.00 | $0 | 20,740 | Nov 6, 2025 |
| May 8, 2025 | BSX BOSTON SCIENTIFIC CORP | AGrant or award Deferred Stock Unitsderivative | +2,081 | $0.00 | $0 | 5,288 | May 9, 2025 |
| May 8, 2025 | BSX BOSTON SCIENTIFIC CORP | AGrant or award Deferred Stock Unitsderivative | +605 | $0.00 | $0 | 5,893 | May 9, 2025 |
| Nov 26, 2024 | CON Concentra Group Holdings Parent, Inc. | AGrant or award Common Stock | +6,496 | $0.00 | $0 | 6,496 | Nov 29, 2024 |
| Nov 26, 2024 | CON Concentra Group Holdings Parent, Inc. | AGrant or award Common Stock | +6,496 | $0.00 | $0 | 12,992 | Nov 29, 2024 |
Questions about Cheryl Pegus
Answered from the filings on this page, as of the latest one.
Is Cheryl Pegus buying or selling?
In the last 12 months Cheryl Pegus reported 1 open-market buy worth $100k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $100k of BSX on May 20, 2026. Grants, option exercises and tax withholding are not counted.
How did Cheryl Pegus's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Cheryl Pegus has 0.
Where does Cheryl Pegus file Form 4?
Cheryl Pegus has filed Form 4 at BSX (BOSTON SCIENTIFIC CORP); CON (Concentra Group Holdings Parent, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.